Page last updated: 2024-10-21

5-hydroxydecanoate and Kidney Diseases

5-hydroxydecanoate has been researched along with Kidney Diseases in 1 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research Excerpts

ExcerptRelevanceReference
"Propofol treatments were initiated at various time intervals: 1 or 24 h before ischemia, only during ischemia, or only during reperfusion."1.35The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion. ( Assad, AR; Capella, MA; Delou, JM; Fonseca, LM; Lopes, AG; Nascimento, JH; Verçosa, N; Villela, NR, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assad, AR1
Delou, JM1
Fonseca, LM1
Villela, NR1
Nascimento, JH1
Verçosa, N1
Lopes, AG1
Capella, MA1

Other Studies

1 other study available for 5-hydroxydecanoate and Kidney Diseases

ArticleYear
The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:5

    Topics: Adenosine Triphosphate; Animals; Antimycin A; Apoptosis; Cell Survival; Cytoprotection; Decanoic Aci

2009